Search
Close this search box.
Search
Close this search box.

GLOBE-NEWSWIRE

CGTN: من الشعب ولأجل الشعب: ما الذي يُكرِّمه “وسام الأول من يوليو”؟

بكين, July 01, 2026 (GLOBE NEWSWIRE) — نشرت شبكة CGTN مقالاً يستكشف القيم التي يجسدها “وسام الأول من يوليو”. ومن خلال قصص المرشحين المُوصى بمنحهم الوسام هذا العام، يسلط المقال الضوء على الكيفية التي ظل بها أجيال من أعضاء الحزب الشيوعي الصيني (CPC) متجذرين بين صفوف الشعب، ومكرسين أنفسهم لخدمة

Read More

Information on the total number of voting rights and shares

REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), June 30, 2026, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of May 2, 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH)

Read More

Information on the total number of voting rights and shares

REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), June 30, 2026, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of May 2, 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH)

Read More

Information on the total number of voting rights and shares

REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), June 30, 2026, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of May 2, 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH)

Read More

New Analyses Advance Understanding of Long-Term Survival Outcomes with Mogamulizumab in Mycosis Fungoides and Sézary Syndrome

Advanced analytical methods integrating clinical trial and real-world data address key evidence gaps in rare, difficult-to-treat blood cancers Across both studies, mogamulizumab was associated with improved survival outcomes compared to standard of care PRINCETON, N.J., June 30, 2026 (GLOBE NEWSWIRE) — Researchers at the World Congress of Cutaneous Lymphoma 2026

Read More